Discover OncoCyte's Q4 2024 progress with its cutting-edge kidney transplant test. Insights on FDA ambitions, market strategies & financial runway.

Q4 2024 Earnings Conference Call March 24, 2025 5:00 PM ETCompany ParticipantsGabby Woody - Executive Assistant, ...

MAG Silver Corp. (TSX / NYSE American: MAG) (“MAG”, or the “Company”) announces the Company’s consolidated financial results for the year ended December 31, 2024. For details of the audited ...

MAG Silver Corp. (TSX / NYSE American: MAG) ("MAG", or the "Company") announces the Company's consolidated financial results for the year ...

Q4 2024 Management View CEO Jacob DeWitte highlighted the strategic advancements in Oklo's advanced nuclear technologies and their alignment with the growing demand for clean energy across sectors ...

In a significant stride toward boosting domestic rare earth resources, American Rare Earths and its subsidiary Wyoming Rare (USA) Inc. are navigating through the development of the Cowboy ...

BISHOPSGATE, LONDON / ACCESS Newswire / / SolGold plc (LSE:SOLG) (TSX:SOLG) is pleased to announce that further to the announcement ...